Fast Market Research recommends "Gene Signal International SA. - Product Pipeline Review - 2012" from Global Markets Direct, now available

Boston, MA -- (SBWire) -- 10/29/2012 --Global Markets Direct's pharmaceuticals report, "Gene Signal International SA. - Product Pipeline Review - 2012" provides data on the Gene Signal International SA.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Gene Signal International SA.'s corporate website, SEC filings, investor presentations and featured press releases, both from Gene Signal International SA. and industry-specific third party sources, put together by Global Markets Direct's team.

View Full Report Details and Table of Contents

Scope

- Gene Signal International SA. - Brief Gene Signal International SA. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Gene Signal International SA. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Gene Signal International SA. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Gene Signal International SA.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to Get this Report

- Evaluate Gene Signal International SA.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Gene Signal International SA. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Gene Signal International SA.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Gene Signal International SA..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Gene Signal International SA. and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Gene Signal International SA. - Product Pipeline Review - H2 2011
- Gene Signal International SA. - Product Pipeline Review - Q1 2011
- Age Related Macular Degeneration - Pipeline Review, H1 2012
- Autoimmune Disorders - Pipeline Review, H2 2012
- Diabetic Retinopathy - Pipeline Review, H1 2012
- Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2012
- Diabetes - Pipeline Review, H1 2012
- Pancreatic Cancer - Pipeline Review, H1 2012
- Retinopathy - Pipeline Review, H1 2012
- Baxter International Inc. - Product Pipeline Review - 2012